RIPK1 Expression Associates with Inflammation in Early Atherosclerosis in Humans and Can be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in Mice.
暂无分享，去创建一个
Richard G. Lee | R. Virmani | J. Fish | F. Kolodgie | K. Rayner | A. Lusis | Patricia Essebier | Calvin Pan | F. Alenghat | U. Hedin | E. Gordon | J. V. van Gils | Liang Guo | Hailey Wyatt | D. Vreeken | Richard G. Jung | A. Rasheed | L. Matic | Jason E. Fish | A. Mompeón | M. Geoffrion | Z. Lister | Joshua W. Kandiah | D. Karunakaran | Peter P. Liu | M. Nguyen | Henry S. Cheng | Nicola Otte | Peter Liu